Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Argentina´S Largest Ethanol Plant Commences Operations

Published: Wednesday, October 30, 2013
Last Updated: Wednesday, October 30, 2013
Bookmark and Share
Vogelbusch technology beats emission standards and allows best-of-breed performance.

Vogelbusch announced the opening of a bioethanol plant in Alejandro Roca, Argentina that is based on its state-of-the-art technology. After a smooth start-up period the production of prime quality bioethanol from the plant owned by Promaíz S.A. has reached full capacity within shortest time. The corn-based ethanol plant has a nameplate capacity of 420,000 liters per day making it the largest of its kind in Argentina. The facility utilizes ethanol technology licensed by Vogelbusch of Austria and is designed for best-of-breed performance in terms of primary energy and freshwater consumption and for full compliance with demanding emission standards.

In Argentina, gasoline must contain 5% ethanol (E5) and the fuel ethanol production is government controlled under a quota system which assigns supply shares to the producers. Now Promaíz S.A. opened its new bioethanol plant in Alejandro Roca in the central Córdoba province of Argentina. The start-up phase of the facility was performed without any problems and full production capacity was reached within less than a month. With a capacity of 420,000 liters per day the plant is the largest of its kind in Argentina and the bioethanol and byproducts (animal feed) produced in the facility are for the domestic markets. The plant will contribute a significant proportion of the national quota of ethanol in future. Promaíz already made its first delivery within this quota system from the new plant in August 2013.

When contracting the building of the new facility Promaíz S.A. especially focused on a optimal utilization of energy and water. In fact the plant is designed for best-of-breed performance in terms of primary energy and freshwater consumption and fully complies with Argentina´s emission standards. This was made possible by state-of-the-art technology by the Austrian innovation leader in this field, Vogelbusch Biocommodities GmbH. "Increased level of legal requirements such as the sustainability criteria for biofuel production in the European Union is an incentive for advanced technology. This we make available to all our clients around the world", comments Torsten Schulze, Managing Director of Vogelbusch Biocommodities GmbH.

"We always attach great importance to the environmental sustainability of plants designed by us", says Ernst Trimmel, Project Manager at Vogelbusch, "At Promaíz´ new plant maximum recycling & recovery of process streams defined the design from the beginning on." This included the Vogelbusch Multicont© continuous fermentation process and the highly energy-efficient multipressure distillation/dehydration system. Air and odor emission at the plant is controlled with the aid of scrubber systems that remove volatile organic components from the exhaust stream and with treatment in a thermal oxidizer.

"Economic processes in combination with sound environmental design play a key part in state-of-the-art bioprocess technology", adds Torsten Schulze. In fact highly efficient plant configurations are a basic design principle of Vogelbusch. The company works on an ongoing basis to refine its technologies with new inputs for energy conservation, recycling and utilization of renewable energy sources.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!